Nutra Pharma Corporation (OTCMKTS:NPHC) Stock Turns Volatile: What’s The Buzz?
Biotech company marketing Nyloxin, Pet Pain-Away, Equine Pain-Away as well as Luxury Feet, Nutra Pharma Corporation (OTCMKTS:NPHC) on July 26, 2021 announced filing a new provisional patent for protecting its IPR surrounding development of nerve agent counter measures. Rik J Deitsch, Chief Executive Officer of Nutra Pharma, said that the firm had announced project back in 2018. Deitsch added that the company findings demonstrate that the company’s products may protect…